Legal & General Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
17,792
+842
+5% +$47.9K ﹤0.01% 2127
2026
Q1
$1.09M Sell
16,950
-3,368
-17% -$307K ﹤0.01% 2112
2025
Q4
$2.64M Buy
20,318
+1,535
+8% +$211K ﹤0.01% 1858
2025
Q3
$2.02M Sell
18,783
-3,488
-16% -$380K ﹤0.01% 1978
2025
Q2
$2.06M Buy
22,271
+7,987
+56% +$627K ﹤0.01% 1953
2025
Q1
$1.27M Buy
14,284
+3,161
+28% +$274K ﹤0.01% 2094
2024
Q4
$855K Buy
11,123
+2,638
+31% +$184K ﹤0.01% 2293
2024
Q3
$360K Buy
8,485
+7,398
+681% +$250K ﹤0.01% 2565
2024
Q2
$28.5K Buy
+1,087
New +$20.6K ﹤0.01% 2893
2023
Q2
Sell
-885
Closed -$10.6K 3525
2023
Q1
$10.6K Sell
885
-328
-27% -$4.37K ﹤0.01% 3200
2022
Q4
$10.6K Hold
1,213
﹤0.01% 3260
2022
Q3
$35K Sell
1,213
-887
-42% -$40.6K ﹤0.01% 3062
2022
Q2
$87K Buy
2,100
+404
+24% +$27.4K ﹤0.01% 2892
2022
Q1
$171K Hold
1,696
﹤0.01% 2724
2021
Q4
$249K Buy
+1,696
New +$379K ﹤0.01% 2626

Other funds holding WGS

Legal & General Group's WGS Position: Q2 2026 in Review

Legal & General Group increased its GeneDx Holdings (WGS) stake by 5% in Q2 2026, buying an estimated $47.9K and bringing the position to 17,792 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Legal & General Group first reported a position in WGS in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.64M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Legal & General Group held 17,792 shares of GeneDx Holdings worth $1.22M as of Q2 2026.
  • Legal & General Group bought 842 GeneDx Holdings shares in Q2 2026, an estimated $47.9K.
  • GeneDx Holdings made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2127 holding.
  • Legal & General Group first reported a position in GeneDx Holdings in Q4 2021 and has held it in 15 quarters since.
  • Legal & General Group's GeneDx Holdings position peaked at $2.64M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.